A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

Abstract

The Huntington's disease (HD) gene has been mapped in 4~16.3 but has eluded identification. We have used haplotype analysis of linkage disequilibrium to spotlight a small segment of 4~16.3 as the likely location of the defect. A new gene, IT15, isolated using cloned trapped exons from the target area contains a polymorphic trinucleotide repeat that is expanded and unstable on HD chromosomes. A (CAG), repeat longer than the normal range was observed on HD chromosomes from all 75 disease families examined, comprising a variety of ethnic backgrounds and 4~16.3 haplotypes. The GAG), repeat appears to be located within the coding sequence of a predicted-346 kd protein that is widely expressed but unrelated to any known gene. Thus, the HD mutation involves an unstable DNA segment, similar to those described in fragile X syndrome, spino-bulbar muscular atrophy, and myotonic dystrophy, acting in the context of a novel 4~16.3 gene to produce a dominant phenotype.

When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada

“…1 It is inherited in an autosomal dominant manner and is caused by a CAG expansion mutation in the HD gene. 2 Although age of onset varies, the mean age of first symptoms is 35-50 years. There is a progression of the cognitive, movement and psychiatric symptoms with death usually occurring 15-20 years after first symptoms.…”

Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease

“…It is inherited in an autosomal dominant manner and is caused by a mutation comprising a CAG trinucleotide expansion in the HD gene. 1 Individuals affected with HD suffer from mood and personality changes, progressive cognitive decline and worsening of the movement disorder, which ends in death approximately 15 -20 years from diagnosis. 2 No therapy is currently available to alter the course of the disease.…”

Developing a comprehensive, effective patient-friendly website to enhance decision making in predictive testing for Huntington disease

“…143100) is a dominantly inherited progressive neuropsychiatric disease caused by a CAG triplet repeat expansion mutation in the huntingtin gene. 1 HD predictive testing (PT) has been available via linkage since 1986 and by direct mutation analysis since 1993. 2 Although there is currently no treatment, testing affords some at-risk individuals benefits such as relieving uncertainty and providing information to make decisions around reproductive choices and financial and insurance planning.…”